Skip to main content

en

     

e-Bulletin    Who's Who ?

 
 
English 
  • English
  • Türkçe
Home

Main navigation

  • Programme Parts
    • Excellent Science
    • European Research Council
    • Marie Skłodowska-Curie Actions
    • Research Infrastructures
    • Global Challenges and European Industrial Competitiveness
    • Health
    • Culture, Creativity and Inclusive Society
    • Civil Security for Society
    • Digital, Industry and Space
    • Climate, Energy and Mobility
    • Food, Bioeconomy, Natural Resources, Agriculture and Environment
    • Joint Research Center
    • Innovative Europe
    • European Innovation Council
    • European Innovation Ecosystems
    • European Institute of Innovation and Technology
    • Expanding Participation and Strengthening ERA
    • Widening Participation and Spreading Excellence
    • Reforming and enhancing the European R&I system
  • Missions
    • A Soil Deal for Europe
    • Healthy Oceans, Seas, Coastal and Inland Waters
    • Adaptation to Climate Change
    • Cancer Mission
    • Climate Neutral and Smart Cities Mission
    • New European Bauhaus
  • Partnerships
  • All Calls
  • Partner Search
  • TUBITAK Supports
  • Cascade Calls

  

Kanser Misyonu 2027 Yılı Alan Çağrıları

  1. Home

Front Menu

  • UFUK2020
    • TURKEY in H2020 Projesi
    • Yenilik Radarı
    • Hedef Türkiye
    • İş Başvuruları
    • Uluslararası İşbirliği Kuruluşları
    • ERA-NET ve Çok Taraflı Programlar
  • DESTEKLER
    • Multinational Research and Innovation Collaboration Grants
    • Frontier Research Individual Grants (European Research Council)
    • Fellowships and Mobility Grants (Marie Sklodowska-Curie Actions)
    • SME Innovation Grants (SME Instrument)
  • PLATFORM VE AĞLAR
  • ÇAĞRILAR
  • ÖDÜLLER
Call Identifier:

HORIZON-MISS-2027-02

Estimated Call Budget:

139.32 Milyon Avro

Call Open Date: 2027-02-10

Call Deadline: 2027-09-21

Call Description:

Cancer: Supporting the implementation of the Cancer Mission

  • HORIZON-MISS-2027-02-CANCER-01: Leveraging functional genomics to reveal novel targets for cancer treatment

  • HORIZON-MISS-2027-02-CANCER-02: Clinical research by Comprehensive Cancer Infrastructures for the benefit of patients with common cancers

  • HORIZON-MISS-2027-02-CANCER-03: Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes

  • HORIZON-MISS-2027-02-CANCER-04: Improving equitable health outcomes and added value for and with cancer patients through health-economics research, health systems research and outcomes research

  • HORIZON-MISS-2027-02-CANCER-05: Pre-commercial procurement of affordable solutions for healthcare systems in the areas of cancer technologies, cancer medical devices, or cancer medicines

  • HORIZON-MISS-2027-02-CANCER-06: Support a Young Cancer Survivor Quality of Life (QoL) research programme by cancer charities and funding agencies

EU Missions' Joint Calls

  • HORIZON-MISS-2027-06-SOIL-CANCER: Living labs to monitor and mitigate carcinogenic substances in and originating from soils: Evaluating their effects on human cancer risks

Call URL:

https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/…

HIZLI ERİŞİM

  • Programme Parts
  • Missions
  • Partnerships
  • All Calls
  • Partner Search
  • TUBITAK Supports
  • Cascade Calls

DİĞER BAĞLANTILAR

  • TUBITAK
  • EUREKA Network
  • COST Network
  • Other Useful Links

İletişim

 +90 312 298 1750
 ufukavrupa[at]tubitak.gov.tr
 
Personal Data Protection Law

location

logo1

logo2

logo3

This website has been produced with the financial support of the European Union and the Republic of Türkiye. Only Sistem Global Danışmanlık is responsible for the content of the publication, and in no way can it be interpreted as reflecting the views of the European Union and the Republic of Türkiye.

Copyright 2021 ©TUBITAK, All Rights Reserved.